TrialMedical oncology (Northwood, London, England)2016
Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience.
M Bupathi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.